•  
  •  
  •  
  •  

2025-10-05 08:23:44

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • HDFC Bank Limited - Business Updates for Q2 FY2026
  • Hindustan Copper Ltd executes Kendadih mining lease deed
  • Bajaj Finance Limited - Q2 FY 2025-26 Business Updates
  • Kranti Industries Ltd inks MOU with KORES Group for JV
  • AU Small Finance Bank Limited - Performance Update for Q2 FY26

Keywords Selected:  INE939A01011

Stock Report

  • Strides strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg
  • Strides acquires identified ANDAs from Nostrum Laboratories, Inc., USA
  • Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio
  • OneSource receives equity commitments of INR 8,010 mn from marquee investors at a pre-money equity valuation of USD 1.65 bn
  • Strides receives USFDA approval for Fluoxetine Tabs 60 mg
  • Strides announces approval from Equity Shareholders and Secured Creditors for creation of OneSource - India's first Specialty Pharma CDMO
  • Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg
  • Strides Pharma Science Ltd gets EIR from USFDA on continued GMP status for the facility in Alathur, Chennai
  • Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg
  • Strides receives USFDA approval for Fluoxetine Tabs 10 mg and 20 mg
  • Strides receives USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg
  • Strides receives USFDA approval for Pregabalin Capsules
  • Stelis Biopharma updates on receipt of consideration from Syngene
  • Strides Pharma Science Ltd provided corporate guarantee to Trinity Pharma Proprietary Ltd's borrowing
  • Stelis Biopharma announces closure of its transaction with Syngene International Ltd
  • Strides launches Icosapent Ethyl Acid Soft Gel Capsules in partnership with Amneal
  • Strides receives USFDA approval for Generic SuprepĀ® Bowel Prep Kit
  • Strides receives USFDA approval for Levetiracetam Oral Solution
  • Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets
  • Strides receives USFDA approval for Icosapent Ethyl Capsules
  • Strides receives USFDA approval for Icosapent Ethyl Capsules
  • Strides receives tentative USFDA approval for Dolutegravir / Lamivudine / Tenofovir Disproxil Fumurate tablets
  • Strides receives tentative USFDA approval for Dolutegravir tablets
  • Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension

Latest Post

  • HDFC Bank Limited - Business Updates for Q2 FY2026
  • Hindustan Copper Ltd executes Kendadih mining lease deed
  • Bajaj Finance Limited - Q2 FY 2025-26 Business Updates
  • Kranti Industries Ltd inks MOU with KORES Group for JV
  • AU Small Finance Bank Limited - Performance Update for Q2 FY26


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024